The histone lysine demethylase KDM4A serves as a coactivator for E2F1, binding to the promoters of PDK1 and PDK3, thus influencing the metabolic transition between glycolysis and mitochondrial oxidation in prostate cancer.36 Here, KDM4A is linked to prostate cancer.